Other Clinical Trial - Weekly Sirolimus Therapy

Status Recruiting

Clinical Trial Summary

In current practice, options for venous and lymphatic malformations remain limited. Recently an oral medication, sirolimus, has been found to benefit patients when taken once or twice a day for several months. Unfortunately there are many side effects associated with this medication, some of which can be severe including, neutropenia, oral ulcerations, and lab abnormalities. The purpose of this study is to determine if once weekly dosed sirolimus will be effective for the treatment of venous and lymphatic malformations. Additionally, the study will evaluate patient satisfaction and identify adverse effects. Participants will be on the medication for 6 months with an option to continue after this time period.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04861064
Study type	Interventional
Source	Medical University of South Carolina
Contact	Stephnie Munie, BS
Phone	843-566-2453
Email	munie@musc.edu
Status	Recruiting
Phase	Phase 2
Start date	January 18, 2022
Completion date	June 2025

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04409145` - First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations	Phase 1/Phase 2
Completed	`NCT05586919` - Treatment of Venous Malformation	N/A
Completed	`NCT04637997` - Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations	N/A
Recruiting	`NCT03767660` - Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation	Phase 4
Completed	`NCT04486599` - Electromagnetic Navigation During Ultrasound Guided Foam Sclerotherapy for Venous Malformations	N/A
Completed	`NCT04930952` - Complications of Ethanol-amine Oleate Intralesional Sclerotherapy
Recruiting	`NCT05563831` - National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Recruiting	`NCT04258046` - Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation	Phase 2
Active, not recruiting	`NCT01347294` - Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations	Phase 4
Completed	`NCT04836884` - Vascular Anomaly Pathology and Genomics Biopsy Study	N/A
Not yet recruiting	`NCT05983159` - A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations	Phase 2